Testing Exercise Intensity and Brain Health in Type 2 Diabetes
Compares high and moderate intensity exercise on brain health in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: The Effect of Exercise on the Brain in Type 2 Diabetes
Key facts
- Where
- Hasselt, BelgiumSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 75 years old?
Source: NCT06734546, who can take part
Where in Belgium
- Hasselt UniversityHasselt, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Hasselt University
- Trial code
- NCT06734546
- Record updated
- 31 March 2026
- Original description
The goal of this clinical trial is to learn if exercise training of high or moderate intensity is most optimal to improve brain health and prevent neurodegeneration in type 2 diabetes patients. The main question it aims to answer is:Read full original descriptionShow less
The Effect of Exercise of High vs. Moderate Intensity on the Brain in Type 2 Diabetes
The goal of this clinical trial is to learn if exercise training of high or moderate intensity is most optimal to improve brain health and prevent neurodegeneration in type 2 diabetes patients. The main question it aims to answer is:
What is the effect of exercise training of high vs. moderate intensity on brain metabolism, brain perfusion, and cognition in type 2 diabetes?
Researchers will compare the exercise training groups to a control group without exercise training to determine the effect of exercise training on the brain in type 2 diabetes.
Participants will exercise for 6 months, 3 times per week. Before and after these 6 months, they will undergo:
* a brain MRI scan * cognitive tests * blood sampling
Inclusion: type 2 diabetes; no insulin therapy; 30-75 years old; physically inactive.
Exclusion: exogenous insulin therapy; psychological disorders; history of coma, transient ischemic attack, head trauma, brain tumor, stroke, epilepsy, and other central nervous system diseases that could cause dementia or presence of dementia before T2DM; suffering from any disease with significant impact on exercise intervention participation such as: chronic heart disease (e.g. valve insufficiency ≥ grade 2) or significant arrhythmias, cardiac events less than one year ago (myocardial infarction, coronary artery bypass graft, percutaneous coronary intervention), clinical heart failure (oedema, shortness of breath), percutaneous coronary intervention less than one year ago, chronic obstructive pulmonary disease (COPD), cerebrovascular or peripheral vascular disease; severe hypertension (>160/110 mmHg); ongoing cancer, severe neuropathy (limiting exercise participation); renal disease (GRF <45 ml/min/1,73 m2); MRI contraindications; inability to regularly participate in the exercise intervention; pregnancy; breastfeeding.